Reuben Ramphal
Overview
Explore the profile of Reuben Ramphal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
2077
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Branton A, Vu C, Venugopalan V, Santevecchi B, Cherabuddi K, Ramphal R, et al.
JAC Antimicrob Resist
. 2023 Mar;
5(2):dlad021.
PMID: 36936190
Objectives: To re-examine the use of non-carbapenems (NCBPs), specifically piperacillin/tazobactam and cefepime, for ESBL-producing Enterobacterales (ESBL-E) urinary tract infections (UTIs). Patients: Retrospective cohort study of adults hospitalized between January 2016...
2.
Vu C, Venugopalan V, Santevecchi B, Voils S, Ramphal R, Cherabuddi K, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Oct;
2(1):e39.
PMID: 36310806
Objective: To re-examine the use of noncarbapenems (NCBPs), specifically piperacillin-tazobactam (PTZ) and cefepime (FEP), for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (ESBL-E BSIs). Design: Retrospective cohort study. Setting: Tertiary-care, academic medical...
3.
Gupte A, Jyot J, Ravi M, Ramphal R
PLoS One
. 2021 Jun;
16(6):e0253259.
PMID: 34115807
Studies of the outcome of Pseudomonas aeruginosa bacteremia (Pab) have focused mainly on antibiotic appropriateness. However, P. aeruginosa possesses many virulence factors whose roles in outcomes have not been examined...
4.
Kalyatanda G, Archibald L, Patnala S, Paul-Satyaseela M, Kiran P, Srinivas S, et al.
Am J Disaster Med
. 2020 Dec;
15(3):219-222.
PMID: 33270212
No abstract available.
5.
Caballero I, Ringot-Destrez B, Si-Tahar M, Barbry P, Guillon A, Lantier I, et al.
J Cyst Fibros
. 2020 Sep;
20(1):173-182.
PMID: 32978064
Background: Bacterial colonization in cystic fibrosis (CF) lungs has been directly associated to the loss of CFTR function, and/or secondarily linked to repetitive cycles of chronic inflammation/infection. We hypothesized that...
6.
Morello E, Perez-Berezo T, Boisseau C, Baranek T, Guillon A, Brea D, et al.
Front Microbiol
. 2019 Sep;
10:1826.
PMID: 31474948
is an opportunistic bacteria and a major cause of nosocomial pneumonia. has many virulence factors contributing to its ability to colonize the host. LoxA is a lipoxygenase enzyme secreted by...
7.
Shah K, Cherabuddi K, Shultz J, Borgert S, Ramphal R, Klinker K
Int J Antimicrob Agents
. 2017 Jul;
51(1):57-61.
PMID: 28666756
Vancomycin-resistant enterococci (VRE) are a common cause of urinary tract infections (UTIs) and are typically multidrug resistant, including ampicillin. This retrospective study evaluated outcomes of 84 adult patients hospitalized between...
8.
Guillon A, Brea D, Morello E, Tang A, Jouan Y, Ramphal R, et al.
Virulence
. 2016 Oct;
8(6):810-820.
PMID: 27792459
The IL-22 signaling pathway is critical for regulating mucosal defense and limiting bacterial dissemination. IL-22 is unusual among interleukins because it does not directly regulate the function of conventional immune...
9.
Guillon A, Chevaleyre C, Barc C, Berri M, Adriaensen H, Lecompte F, et al.
PLoS One
. 2015 Nov;
10(11):e0143459.
PMID: 26600426
Background: Cystic Fibrosis (CF) is the most prevalent autosomal recessive disease in the Caucasian population. A cystic fibrosis transmembrane conductance regulator knockout (CFTR-/-) pig that displays most of the features...
10.
Balloy V, Thevenot G, Bienvenu T, Morand P, Corvol H, Clement A, et al.
BMC Pulm Med
. 2014 Jun;
14:100.
PMID: 24909229
Background: The aim was to measure flagellin concentrations in the expectorations of CF patients and to examine whether there are correlations with the level of respiratory insufficiency and inflammation. Methods:...